Skip to content
PQ Bypass logo — Leading the charge in minimally-invasive treatments for long...

PQ Bypass

Leading the charge in minimally-invasive treatments for long-segment peripheral artery disease with deep industry expertise and innovation-driven solutions

Founded 2009 Private Equity Total: $70.04M Health Care, Medical Devices

General Information

Company Name PQ Bypass
Founded Year 2009
Industries Health Care, Medical Devices
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with PQ Bypass. To contact PQ Bypass, visit pqbypass.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PQ Bypass compare?

A PDF of PQ Bypass and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PQ Bypass soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PQ Bypass

**PQ Bypass** is a Silicon Valley-based medical device company aiming to enhance the treatment of long-segment peripheral artery disease through minimally-invasive endovascular solutions. Founded in **2009**, it was previously a Company-In-Residence at the Fogarty Institute for Innovation. The leadership team comprises professionals with extensive experience in the medical device sector, having held senior roles at renowned companies such as **Medtronic**, **Abbott**, **Johnson & Johnson**, **Covidien**, and **Stryker**, while also contributing to the development of medical devices for venture-backed startups like **Evalve**, **AccessClosure**, **Altura**, and **DVI**. The company recently secured a significant **$60.00M** Private Equity Round investment on **08 January 2019**. This funding round saw participation from notable investors including **Medical Technology Venture Partners**, **Seroba Life Sciences**, and **Deerfield Capital Management**. PQ Bypass' dedication to innovation and its leadership's deep industry expertise position the company as a pivotal player in the minimally-invasive treatments realm within the **Health Care** and **Medical Devices** industries. With its strong investor backing and experienced leadership, PQ Bypass is primed to make a significant impact in the medical device landscape.

Business keywords: medical device industry, minimally-invasive treatments, endovascular solutions, peripheral artery disease, Silicon Valley, Fogarty Institute for Innovation, venture-backed startups, Medtronic, Abbott, Johnson & Johnson, Covidien, Stryker, evalve, AccessClosure, DVI

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $60.00M 3
Medical Technology Venture Partners, Seroba Life Sciences +1
08 Jan 2019
Venture Round $10.04M -
22 Apr 2016

PQ Bypass Alternatives & Competitors

View All Alternatives
PQ Bypass vs
Intact Vascular
Intact Vascular United States

Founded in 2011, Intact Vascular located in Wayne, PA is a privately held medical device company tha...

Debt Financing
6 employees
Health Care, Manufacturing
PQ Bypass vs
Ra Medical Systems
Ra Medical Systems United States

Our Mission: Save lives, limbs and improve patients’ quality of life.

Post-IPO Equity
36 employees
Health Care, Medical Devices
PQ Bypass vs

Pioneering biodegradable nanoparticle technology for safer cardiovascular treatments.

Series A
2-10 employees
Health Care, Health and Wellness

FAQ About PQ Bypass

Leading the charge in minimally-invasive treatments for long-segment peripheral artery disease with deep industry expertise and innovation-driven solutions
PQ Bypass was founded in 2009.
PQ Bypass operates in Health Care and Medical Devices. Its work centres on medical device industry, minimally-invasive treatments, endovascular solutions and peripheral artery disease.
PQ Bypass has completed 2 funding rounds, raising a total of $70.04M. The latest funding stage is Private Equity.
Top alternatives and competitors to PQ Bypass include Intact Vascular, Ra Medical Systems, Advanced NanoTherapies, Silk Road Medical, Inc., Cagent Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PQ Bypass and Intact Vascular are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PQ Bypass, https://bouncewatch.com/company/pq-bypass, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout